Idorsia Ltd (OTCMKTS:IDRSF – Get Free Report)’s share price traded down 7.4% during mid-day trading on Wednesday . The stock traded as low as $1.00 and last traded at $1.00. 155 shares traded hands during trading, a decline of 94% from the average session volume of 2,738 shares. The stock had previously closed at $1.08.
Idorsia Stock Performance
The business’s 50 day simple moving average is $2.15 and its 200 day simple moving average is $2.30.
Idorsia Company Profile
Idorsia Ltd, a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland. The company has a clinical development pipeline that cover various therapeutic areas, including CNS, cardiovascular, and immunological disorders, as well as orphan diseases.
Featured Stories
- Five stocks we like better than Idorsia
- 3 Stocks to Consider Buying in October
- Rocket Lab is the Right Stock for the Right Time
- Dividend Capture Strategy: What You Need to Know
- SoundHound AI Will Advance By Triple Digits in 2025: Here’s Why
- 10 Best Airline Stocks to Buy
- Celsius Holdings: Big Drop, Big Opportunity? Analysts Say Yes
Receive News & Ratings for Idorsia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Idorsia and related companies with MarketBeat.com's FREE daily email newsletter.
